Emily Baumrin, MD, MSCE; Daniel B. Shin, PhD; Nandita Mitra, PhD; et al.
JAMA Dermatol. 2024;160(4):393-401. doi:10.1001/jamadermatol.2023.6277
This cohort study examines the association of chronic graft-vs-host disease subtype with patient-reported outcomes and evaluates whether these measures can identify patients at higher risk for death.
Reza Ghiasvand, PhD; Adele C. Green, MBBS, PhD; Marit B. Veierød, PhD; et al.
open access
JAMA Dermatol. 2024;160(4):402-408. doi:10.1001/jamadermatol.2023.6251
This cohort study assesses the incidence rate of second primary invasive melanoma at least 30 days after the first based on data from deidentified records of all invasive melanomas diagnosed in 2008 to 2020, obtained from the Cancer Registry of Norway.
Alexander C. Egilman, BA; Aaron S. Kesselheim, MD, JD, MPH; Jerry Avorn, MD; et al.
JAMA Dermatol. 2024;160(4):409-416. doi:10.1001/jamadermatol.2023.6236
This economic evaluation assesses how the efficiency frontier approach could align prices and clinical benefits of biologic medications for plaque psoriasis and estimates price reductions in the US vs 4 peer countries.
Nour Kibbi, MD; Joshua L. Owen, MD, PhD; Brandon Worley, MD, MSc; et al.
JAMA Dermatol. 2024;160(4):417-424. doi:10.1001/jamadermatol.2024.0001
This meta-analysis examines demographic and tumor characteristics and treatment approaches for different extramammary Paget disease subtypes and presents recommendations for diagnosis and treatment.
Juzi Liu, MD; Jing Wang, MD, PhD; Qian Zhang, MD; et al.
has multimedia
JAMA Dermatol. 2024;160(4):425-433. doi:10.1001/jamadermatol.2023.5908
This nonrandomized trial examines the antisclerotic and regenerative effects of sequential fat grafting with fresh fat and cryopreserved stromal vascular fraction gel for morphea.